106 related articles for article (PubMed ID: 1314461)
41. Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences.
Münger K; Yee CL; Phelps WC; Pietenpol JA; Moses HL; Howley PM
J Virol; 1991 Jul; 65(7):3943-8. PubMed ID: 1645802
[TBL] [Abstract][Full Text] [Related]
42. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
43. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy.
Garbuglia AR; Carletti F; Minosse C; Piselli P; Zaniratti MS; Serraino D; Capobianchi MR
New Microbiol; 2007 Oct; 30(4):377-82. PubMed ID: 18080672
[TBL] [Abstract][Full Text] [Related]
44. Induction of chromosome abnormalities in mouse and human epidermal keratinocytes by the human papillomavirus type 16 E7 oncogene.
Hashida T; Yasumoto S
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1569-77. PubMed ID: 1649895
[TBL] [Abstract][Full Text] [Related]
45. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins.
Georgopoulos NT; Proffitt JL; Blair GE
Oncogene; 2000 Oct; 19(42):4930-5. PubMed ID: 11039910
[TBL] [Abstract][Full Text] [Related]
46. Differential cooperation of a carcinogen with human papillomavirus type 6 and 16 DNAs in in vitro oncogenic transformation.
Mitrani-Rosenbaum S; Tsvieli R
Intervirology; 1992; 33(2):76-85. PubMed ID: 1314784
[TBL] [Abstract][Full Text] [Related]
47. Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions.
Buonaguro FM; Tornesello ML; Buonaguro L; Del Gaudio E; Beth-Giraldo E; Giraldo G
Antibiot Chemother (1971); 1994; 46():102-9. PubMed ID: 7826030
[No Abstract] [Full Text] [Related]
48. E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China.
Chen Z; Jing Y; Wen Q; Ding X; Wang T; Mu X; Chenzhang Y; Cao M
PLoS One; 2017; 12(1):e0171140. PubMed ID: 28141822
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
Massimi P; Pim D; Banks L
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
[TBL] [Abstract][Full Text] [Related]
50. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
Gammoh N; Grm HS; Massimi P; Banks L
J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
Tan TM; Gloss B; Bernard HU; Ting RC
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.
Caldeira S; de Villiers EM; Tommasino M
Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500
[TBL] [Abstract][Full Text] [Related]
53. HPV-16 E6 and E7 genes, like SV40 early region genes, are insufficient for immortalization of human mesothelial and bronchial epithelial cells.
De Silva R; Whitaker NJ; Rogan EM; Reddel RR
Exp Cell Res; 1994 Aug; 213(2):418-27. PubMed ID: 8050498
[TBL] [Abstract][Full Text] [Related]
54. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.
Antinore MJ; Birrer MJ; Patel D; Nader L; McCance DJ
EMBO J; 1996 Apr; 15(8):1950-60. PubMed ID: 8617242
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus type 16 E7-regulated genes: regulation of S100P and ADP/ATP carrier protein genes identified by differential-display technology.
Hellung Schønning B; Bévort M; Mikkelsen S; Andresen M; Thomsen P; Leffers H; Norrild B
J Gen Virol; 2000 Apr; 81(Pt 4):1009-15. PubMed ID: 10725427
[TBL] [Abstract][Full Text] [Related]
56. Identification and location of human papillomavirus type 16 antisense early promoter and characterisation of antisense RNA.
Belaguli NS; Pater MM; Pater A
J Med Virol; 1997 Apr; 51(4):344-54. PubMed ID: 9093951
[TBL] [Abstract][Full Text] [Related]
57. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
[TBL] [Abstract][Full Text] [Related]
58. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China.
Stephen AL; Thompson CH; Tattersall MH; Cossart YE; Rose BR
Int J Cancer; 2000 Jun; 86(5):695-701. PubMed ID: 10797293
[TBL] [Abstract][Full Text] [Related]
59. The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31.
Longworth MS; Laimins LA
J Virol; 2004 Apr; 78(7):3533-41. PubMed ID: 15016876
[TBL] [Abstract][Full Text] [Related]
60. Cloning of E6 and E7 genes of human papilloma virus type 18 and transformation potential of E7 gene and its mutants.
Laassri M; Gul'ko L; Vinokurova S; Kisseljova N; Veiko V; Kisseljov F
Virus Genes; 1999; 18(2):139-49. PubMed ID: 10403700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
